Avience Biomedicals Peer Comparison

NSE: AVIENCE

₹270.50

₹-2.00 (-0.73%)

As on 03-Sep-2026 15:59IST

Market cap

₹148 Cr

Revenue (TTM)

₹45 Cr

P/E Ratio

17

P/B Ratio

2.8

Div. Yield

0 %

Edit

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Market cap (₹ Cr)	148	17,930	1,487	614	319
Revenue (₹ Cr)	45	1,997	314	92	153
Net Profit (₹ Cr)	7.23	307.01	24.51	4.71	4.34
Net Margin (%)	15.73	14.56	7.60	5.06	2.70
RoE (%)	49.90	10.63	13.94	4.92	2.29
Price to Earnings	16.95	56.91	26.69	49.93	73.48
Price-To-Book	2.80	5.63	7.03	4.39	1.73

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Operating Revenue	45.24	1,669.83	313.78	92.43	109.66
Total Income	45.97	1,758.96	322.58	93.00	122.37
Total Expenditure	33.79	1,214.12	239.29	82.12	117.47
EBITDA	11.45	455.71	74.49	10.31	-7.81
Depreciation	0.86	83.18	7.32	3.89	2.34
EBIT	10.59	372.53	67.17	6.42	-10.15
Interest	1.52	14.32	14.81	0.41	1.21
Other Income	0.73	89.13	8.80	0.57	12.71
Exceptional Items	--	--	-16.97	--	--
Profit before Tax	9.80	452.52	44.19	6.59	1.34
Provision for Tax	2.57	113.96	19.68	1.88	0.50
Profit after Tax	7.23	338.56	24.51	4.71	0.85

Liabilities (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Shareholder's Funds	22.78	2,765.66	189.95	98.04	194.29
Minority Interest	--	--	--	--	--
Non-Current Liabilities	10.16	56.40	85.42	14.44	-0.18
Current Liabilities	23.51	457.71	179.14	18.62	12.40
Total Liabilities	56.45	3,279.77	455.49	131.33	209.98

Assets (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Non-Current Assets	19.28	1,269.89	189.87	76.67	16.55
Current Assets	37.17	2,009.87	264.64	54.44	189.95
Total Assets	56.45	3,279.77	455.49	131.33	209.98
Total Debt*	22.16	177.65	166.29	17.82	2.37
Net Current Assets	13.66	1,552.17	85.50	35.81	177.55
Contingent Liabilities	0.40	77.12	--	5.29	0.02

Cashflow (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Cash From Operating Activities	3.61	233.05	-1.28	3.02	-19.08
Cash Flow from Investing Activities	-8.81	-1,187.18	-59.13	-14.74	8.44
Cash from Financing Activities	9.25	950.51	53.34	-0.60	-0.17
Net Cash Inflow / Outflow	4.05	-3.63	-7.07	-12.32	-10.81

Ratios

Profitability Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
ROCE (%)	34.16	20.37	19.19	6.16	1.31
ROE (%)	49.90	16.01	13.94	4.92	0.44
ROA (%)	15.90	12.99	6.18	3.60	0.42
EBIT Margin (%)	26.92	32.63	26.54	11.77	4.46
Net Margin (%)	15.73	19.25	7.60	5.06	0.69
Cash Profit Margin (%)	17.89	25.15	10.15	7.98	2.61

Growth Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Revenue Growth (%)	88.77	21.37	54.08	-24.14	19.29
EBIT Growth (%)	169.91	30.11	103.82	-46.94	1,494.46
Net Profit Growth (%)	237.76	31.09	13.27	-58.34	147.16
EPS Growth (%)	175.19	24.16	-18.34	-58.34	147.16
Book Value Growth (%)	266.73	88.41	17.38	5.05	0.61

Valuation Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Price / Earnings	0.00	67.10	0.00	48.10	248.64
Price / Book Value	0.00	8.22	0.00	2.31	1.08
Dividend Yield (%)	--	0.16	--	0.00	0.00
EV/EBITDA	1.75	41.75	1.45	22.15	17.43
Market Cap (₹ Cr)	0.00	22,718.23	0.00	226.53	210.35

Solvency Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Debt to Equity	0.97	0.06	0.88	0.18	0.01
Short term debt to equity ratio	0.50	0.06	0.29	0.00	0.00
Current Ratio	1.58	4.39	1.48	2.92	15.32
Quick Ratio	1.03	3.77	0.97	1.83	12.10
Interest Coverage	7.45	32.59	3.98	17.26	2.11

Operating Efficiency Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	Nureca
Debtors to sales (%)	38.05	20.94	26.32	23.68	3.03
Asset Turnover	0.99	0.64	0.79	0.82	0.60
Receivable days	102.08	67.43	63.42	66.41	7.39
Inventory Days	102.74	55.13	113.68	71.27	105.87
Payable days	86.43	74.14	143.90	54.28	31.48
Cash Conversion Cycle	118.39	48.42	33.20	83.40	81.78